Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Total Non-Current Liabilities: 2019-2024

Historic Total Non-Current Liabilities for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $364.9 million.

  • Beam Therapeutics' Total Non-Current Liabilities fell 9.71% to $338.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $338.4 million, marking a year-over-year decrease of 9.71%. This contributed to the annual value of $364.9 million for FY2024, which is 23.29% down from last year.
  • Latest data reveals that Beam Therapeutics reported Total Non-Current Liabilities of $364.9 million as of FY2024, which was down 23.29% from $475.7 million recorded in FY2023.
  • In the past 5 years, Beam Therapeutics' Total Non-Current Liabilities registered a high of $616.3 million during FY2021, and its lowest value of $204.0 million during FY2020.
  • In the last 3 years, Beam Therapeutics' Total Non-Current Liabilities had a median value of $475.7 million in 2023 and averaged $478.8 million.
  • Per our database at Business Quant, Beam Therapeutics' Total Non-Current Liabilities skyrocketed by 272.77% in 2020 and then decreased by 23.29% in 2024.
  • Yearly analysis of 5 years shows Beam Therapeutics' Total Non-Current Liabilities stood at $204.0 million in 2020, then spiked by 202.07% to $616.3 million in 2021, then fell by 3.34% to $595.8 million in 2022, then fell by 20.16% to $475.7 million in 2023, then dropped by 23.29% to $364.9 million in 2024.